LONDON, UNITED KINGDOM, November 21, 2024 /
EINPresswire.com/ -- Noventia Pharma is a speciality pharmaceutical Company based in Milano, Italy. Founded in 2009 and with operations in Southern Europe, Noventia’s focus is the research, development, and marketing of Orphan Drugs.
Massimo Radaelli is the Founder, President and CEO of Noventia Pharma, and also the CEO and Board Member of Napo Therapeutics. Both companies have Rare Diseases as their primary focus.
The interview is available to view here:
https://www.youtube.com/watch?v=oXzL_hOalYw
and on The European’s website here:
https://the-european.eu/story-40290/video-interview-with-massimo-radaelli.html
About The European:
The European is a quarterly business publication, published by CP Media Global Limited in London. It is available in hard copy, digital format and is accessible at various trade fairs around the world.
Jonathan Edwards
CP Media Global Limited
email us here
Visit us on social media:
Twitter